🟢 Eli Lilly is trading 4.02% up amid healthcare sector gains

Eli Lilly is trading 4.02% higher at ARS 34,680.00 on October 7, 2026; no fresh company-specific announcement clearly explains the move.

• Available coverage shows only modest premarket gains for the U.S.-listed shares; healthcare is up 1.25%, offering supportive sector context rather than a confirmed direct cause.
• Broader U.S. markets are lower amid elevated Treasury yields, oil prices, and caution ahead of the Federal Reserve minutes. Available evidence does not independently explain the size of the Argentine-listed move.